Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.
The key risk here is that KDP is possibly overpaying for the acquisition of JDE. KDP will pay JDE Peet’s shareholders €31.85 ...
Nearly 800 sensors feed data back to an operations center that helps the Oracle Red Bull crew make split-second decisions.
5d
FireFly Metals announces Mineral Resource increased by 51% at Green Bay Copper Gold Project, Canada
Exceptional result includes a spectacular high-grade Mineral Resource of 8.8Mt @ 3.9% CuEq (346kt CuEq) in M&I and 10.9Mt @ 3 ...
Exceptional result includes a spectacular high-grade Mineral Resource of 8.8Mt @ 3.9% CuEq (346kt CuEq) in M&I and 10.9Mt @ 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback